Clinical Trials Directory

Trials / Completed

CompletedNCT07194408

In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic Dermatitis

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Pierre Fabre Dermo Cosmetique · Industry
Sex
All
Age
3 Years – 11 Years
Healthy volunteers
Not accepted

Summary

Atopic dermatitis is a chronic skin condition requiring sun protection, yet research on sunscreen effectiveness and skin tolerance in Atopic Dermatitis is limited. This study evaluates a broad-spectrum SPF50+ sunscreen on 22 children with Atopic Dermatitis, assessing skin tolerance through dermatologic and pediatric controls.

Detailed description

Atopic dermatitis is a chronic skin condition that necessitates sun protection, yet there is limited research on the effectiveness of sunscreens and skin tolerance in Atopic Dermatitis. Objectives: This study aims to evaluate the tolerance of a broad-spectrum SPF50+ sunscreen in children with Atopic Dermatitis, monitored through dermatological and pediatric assessments. Methods: This study is conducted on 22 children with Atopic Dermatitis confirmed using the SCORAD index (15-25). The protocol includes 2 visits and assessments as follow: * Visit 1: Inclusion (Day 1) - Before and immediately after application (10 to 30 minutes), the investigator conducts a clinical evaluation of the dermatological tolerance of the investigational product. SCORAD evaluation by the dermatologist and pediatrician together is performed on Day 1. * Home Application Period: Day 1 to Day 22 - Continued application of the sunscreen at home in real conditions of use * Visit 3: End of Study (Day 22) -The investigators conduct a clinical evaluation of the dermatological tolerance of the investigational product. In addition, a questionnaire is used to evaluate global and perceived efficacy of the sunscreen.

Conditions

Interventions

TypeNameDescription
OTHERSunscreen RV4620A RP2552Dermo-cosmetic product, Broadspectrum Sunscreen RV4620A RP2552, very high protection product. Instructions for product use given to the subjects: Apply before and during sun exposure, at least twice daily. During sun exposure, applications must be renewed as often as necessary, in particular after swimming, perspiring, towelling, in order to ensure a good protection. On days of bad weather, apply the product in the morning and at the beginning of the afternoon.

Timeline

Start date
2023-12-12
Primary completion
2024-02-16
Completion
2024-02-16
First posted
2025-09-26
Last updated
2025-09-26

Locations

1 site across 1 country: Mauritius

Source: ClinicalTrials.gov record NCT07194408. Inclusion in this directory is not an endorsement.